Characteristics and dissemination of phase I trials approved by a UK Regional Office in 2012
Oversights in the design and conduct of phase I trials have resulted in morbidity and mortality1,2. Empirical evidence to improve regulatory review of phase I trials is lacking. We studied the characteristics of phase I trials, frequency of harms, and dissemination of results.
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Medical Association
2017
|